NMD Pharma A/S — Credit Rating and Financial Key Figures

NMD Pharma A/S (CVR number: 36899069K) is a company from AARHUS. The company recorded a gross profit of -4661.8 kEUR in 2018. The operating profit was -6170 kEUR, while net earnings were -5542.8 kEUR. The profitability of the company measured by Return on Assets (ROA) was -114.7 %, which can be considered poor and Return on Equity (ROE) was -129 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 85.2 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. NMD Pharma A/S's liquidity measured by quick ratio was 6.8 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.